Seven Mile Advisory’s Gilead Sciences GILD Stock Holding History

Seven Mile Advisory’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$425K	Sell	3,052 -1,535	-33%	-$215K	0.31%	69
2025 Q4	$563K	Sell	4,587 -571	-11%	-$69.4K	0.1%	104
2025 Q3	$573K	Buy	5,158 +2,060	+66%	+$234K	0.09%	114
2025 Q2	$343K	Buy	3,098 +344	+12%	+$36.6K	0.21%	101
2025 Q1	$309K	Buy	2,754 +86	+3%	+$8.87K	0.21%	108
2024 Q4	$246K	Buy	+2,668	New	+$240K	0.16%	124
2023 Q4	–	Sell	-2,941	Closed	-$220K	–	154
2023 Q3	$220K	Buy	+2,941	New	+$226K	0.23%	101

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Seven Mile Advisory's GILD Position: Q1 2026 in Review

Seven Mile Advisory reduced its Gilead Sciences (GILD) stake by 33% in Q1 2026, selling an estimated $215K and leaving 3,052 shares worth $425K. The position accounts for 0.31% of the portfolio, ranked #69.

Seven Mile Advisory first reported a position in GILD in Q3 2023 and has held it in 7 quarters since. The position peaked at $573K in Q3 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Seven Mile Advisory held 3,052 shares of Gilead Sciences worth $425K as of Q1 2026.
Seven Mile Advisory sold 1,535 Gilead Sciences shares in Q1 2026, an estimated $215K.
Gilead Sciences made up 0.31% of Seven Mile Advisory's portfolio in Q1 2026, its #69 holding.
Seven Mile Advisory first reported a position in Gilead Sciences in Q3 2023 and has held it in 7 quarters since.
Seven Mile Advisory's Gilead Sciences position peaked at $573K in Q3 2025.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Seven Mile Advisory's 13F filing for Q1 2026, filed 14 Apr 2026.